Stoke Therapeutics
STOK
STOK
130 hedge funds and large institutions have $640M invested in Stoke Therapeutics in 2024 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 40 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
2% less repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 41
10% less capital invested
Capital invested by funds: $715M → $640M (-$75M)
86% less call options, than puts
Call options by funds: $38K | Put options by funds: $263K
Holders
130
Holding in Top 10
3
Calls
$38K
Puts
$263K
Top Buyers
| 1 | +$35M | |
| 2 | +$22.1M | |
| 3 | +$5.2M | |
| 4 |
BlackRock
New York
|
+$3.5M |
| 5 |
TCM
Tang Capital Management
San Diego,
California
|
+$3.31M |
Top Sellers
| 1 | -$22.1M | |
| 2 | -$8.47M | |
| 3 | -$7.93M | |
| 4 |
Jane Street
New York
|
-$3.51M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$1.91M |